Company Filing History:
Years Active: 2013
Title: Simon Schnaiter: Innovator in Hematological Cancer Treatment
Introduction
Simon Schnaiter is a notable inventor based in Kolsass, Austria. He has made significant contributions to the field of medical intervention, particularly in the treatment of hematological cancers. His innovative approach focuses on the pharmaceutical use of specific compounds to enhance cancer therapy.
Latest Patents
Simon Schnaiter holds a patent for his invention titled "Medical intervention in haematological cancers." This patent relates to the medical and pharmaceutical use of substituted 1H-imidazo[4,5-c]quinolin-4-amines, specifically Imiquimod® and Gardiquimod®, either alone or in combination with Akt inhibitors. The invention aims to treat, prevent, and ameliorate hematological cancers, particularly multiple myeloma disorders and B-cell disorders.
Career Highlights
Schnaiter is associated with Oncotyrol - Center for Personalized Cancer Medicine GmbH, where he applies his expertise in cancer research and treatment. His work is pivotal in advancing personalized medicine approaches for cancer patients.
Collaborations
He collaborates with esteemed colleagues such as Lukas A. Huber and Inge Tinhofer, contributing to a multidisciplinary approach in cancer research and treatment.
Conclusion
Simon Schnaiter is a key figure in the field of hematological cancer treatment, with a focus on innovative pharmaceutical applications. His contributions are vital for the ongoing development of effective cancer therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.